GEN3014

· Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN3014, covering 2025-12-22 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]